GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Tax Rate %

CGON (CG Oncology) Tax Rate % : 0.00% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CG Oncology Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. CG Oncology's Tax Expense for the three months ended in Sep. 2024 was $0.00 Mil. CG Oncology's Pre-Tax Income for the three months ended in Sep. 2024 was $-20.41 Mil. Therefore, CG Oncology's Tax Rate % for the quarter that ended in Sep. 2024 was 0.00%.


CG Oncology Tax Rate % Historical Data

The historical data trend for CG Oncology's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CG Oncology Tax Rate % Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23
Tax Rate %
- - -

CG Oncology Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CG Oncology Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

CG Oncology's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2023 )/Pre-Tax Income (A: Dec. 2023 )
=0/-48.607
=0.00 %

CG Oncology's Tax Rate % for the quarter that ended in Sep. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Sep. 2024 )/Pre-Tax Income (Q: Sep. 2024 )
=0/-20.405
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CG Oncology Tax Rate % Related Terms

Thank you for viewing the detailed overview of CG Oncology's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.


CG Oncology Business Description

Traded in Other Exchanges
N/A
Address
400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.